Literature DB >> 10532597

Ultraviolet and visible light spectrophotometric approach to blood typing: objective analysis by agglutination index.

S Narayanan1, S Orton, G F Leparc, L H Garcia-Rubio, R L Potter.   

Abstract

BACKGROUND: A new blood typing technology based on ultraviolet (UV) and visible light spectroscopy (UV/visible spectroscopy) has been developed. Blood groups and types are determined by quantifying reproducible changes in the UV and visible light spectra of blood in the presence of agglutinating antibodies. STUDY DESIGN AND METHODS: Samples of red cells in the presence and absence of agglutinating antibodies were examined by UV/visible spectroscopy. Blood groups and types were determined by comparing the optical density spectra obtained between 665 and 1000 nm. These comparisons generate numbers (agglutination index) ranging from 0 to 100, with smaller numbers corresponding to lack of agglutination and larger numbers corresponding to agglutination.
RESULTS: The optical density of agglutinated blood is dramatically different from that of unagglutinated blood. The agglutination index derived from the relative slopes of the spectra is an objective indicator of agglutination strength. An agglutination index greater than 17 consistently and accurately established blood group- and type-specific agglutination.
CONCLUSION: The method accurately predicted A, B, and O blood groups, and D type in over 275 samples. Scattering theory-based calculations of relative volumes of red cells before and after agglutination show a direct correlation with the agglutination index and provide the theoretical basis of the analysis. This quantitative technique is reproducible and has the potential for automation.

Mesh:

Year:  1999        PMID: 10532597     DOI: 10.1046/j.1537-2995.1999.39101051.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  1 in total

1.  Hypochromicity in red blood cells: an experimental and theoretical investigation.

Authors:  Akihisa Nonoyama; Alicia Garcia-Lopez; Luis H Garcia-Rubio; German F Leparc; Robert L Potter
Journal:  Biomed Opt Express       Date:  2011-07-01       Impact factor: 3.732

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.